Fundraising Fox

Regina Hodits

Investor

Managing Director at Angelini Ventures

Munich

About

Regina Hodits is a Managing Director at Angelini Ventures. She previously served as Managing Partner at Wellington Partners Life Sciences and led the European life sciences efforts of Atlas Venture, and earlier worked at Apax Partners and McKinsey. She studied chemical engineering in Vienna, holds a Ph.D. in biochemistry, and conducted post-doctoral research at the MRC in Cambridge, UK.

Invests in

BiotechDigital HealthMedical Devices

Experience

  1. Angelini VenturesManaging Directorcurrent2025 — presentMunich, Germany
  2. Wellington Partners Life SciencesVenture Advisorcurrent2025 — presentMunich, Germany
  3. Wellington Partners Life SciencesManaging Partner2010 — 2025Munich, Germany
  4. INiTS | Vienna's High-Tech IncubatorChairperson of the Board - Pro-Bonocurrent2012 — presentVienna, Austria
  5. BioInnovation InstituteBoard Membercurrent2020 — presentCopenhagen, Denmark
  6. EIT Health GermanyMember of the Expert Council - Pro-Bono2019 — 2024
  7. BVK Bundesverband Deutscher KapitalbeteiligungsgesellschaftenSpokesperson of the Board of Directors2015 — 2020Berlin, Germany
  8. GSK GlaxoSmithKlineExternal Director Respiratory Therapeutic Area Board2008 — 2014London, UK
  9. Atlas VentureGeneral Partner- Life Sciences2004 — 2010Munich GER London UK
  10. Apax PartnersInvestment Manager2000 — 2004Munich, Germany
  11. McKinsey & CompanyEngagement Manager1997 — 2000Vienna AUT / London UK / Munich GER
  12. Medical Research CouncilPost-Doctoral Researcher at Sir Gregory Winter's lab1995 — 1997Cambridge UK
  13. University of Vienna, Institute of BiochemistryScientific Team Leader & University Lecturer1993 — 1995Vienna AUT

Education

  1. Technische Universität WienDoctorate of Science / Biochemistry
  2. McKinsey & Company Clearwater, USAExecutive MBA course
  3. Technische Universität WienMasters of Science / Chemical Engineering

Skills & more

Venture Capital22Unternehmensentwicklung15Fusionen und Übernahmen11Biowissenschaften14Corporate Development3Risikoprüfung4Strategisches Management6Start-ups31Biotechnologie6Unternehmensstrategie4Privates Eigenkapital3Pharmaindustrie12
+10 moreUnternehmertumTechnologietransferUnternehmensleitungDue DiligenceBusiness DevelopmentRisikokapitalLife SciencesRiskokapitalGeschäftsentwicklungStrategie

Languages Deutsch · Englisch · Spanisch

From Regina's professional profile.

Same school

Shared employers

Investments

Board seats

CarismaMinervaxNitec PharmaNovamedONWARDSeamlessSidekickSidekick HealthSNIPR BiomeStipeTRiCaresU3 Pharma

Investor

Atopix TherapeuticsBicycle TherapeuticsF-starJenavalveMiddle Peak MedicalOnwardRigontecSapiensSapiens MedicalThemisThemis Medical

Per the firm's website.

Colleagues at Angelini Ventures

Network1

Investors connected to Regina in public investor directories — a warm-intro map.